What amount sold does SEALSQ Corp report in Form D filings?

The latest linked filings report $135.2M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was SEALSQ Corp's most recent SEC filing?

SEALSQ Corp's most recent Form D filing was on 2025-10-22.

How many investors does SEALSQ Corp have?

The most recent Form D filing lists 5 investor(s).

SEALSQ Corp

CIK: 0001951222·Other Technology·COINTRIN, V8·Other·Founded 2022

Reported Sold

$135,199,118

Total Filings

Identified Offerings

Last Filed

Oct 22, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Oct 22, 2025Form D — New notice

Reported sold: $105,199,118 · Target: $105,199,118

Rule 506(b)·5 investors

Mar 11, 2024Form D — New notice

Reported sold: $10,000,000 · Target: $10,000,000

Rule 506(b)·2 investors

Jan 17, 2024Form D — New notice

Reported sold: $10,000,000 · Target: $10,000,000

Rule 506(b)·2 investors

Jul 21, 2023Form D — New notice

Reported sold: $10,000,000 · Target: $10,000,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$7,811,947

Amendment Rate

Latest reported sold across 4 identified offerings

$135,199,118

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Carlos Moreira

Related Person

Appears on 4 filings

Peter Ward

Related Person

Appears on 4 filings

Cristina Dolan

Related Person

Appears on 4 filings

David Fergusson

Related Person

Appears on 4 filings

Eric Pellaton

Related Person

Appears on 4 filings

Nathalie Verjus

Related Person

Appears on 4 filings

John O'Hara

Related Person

Appears on 4 filings

Bernard Vian

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 22, 2025	New	$105,199,118	$105,199,118	5
Mar 11, 2024	New	$10,000,000	$10,000,000	2
Jan 17, 2024	New	$10,000,000	$10,000,000	2
Jul 21, 2023	New	$10,000,000	$10,000,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Rgenta Therapeutics, Inc.

Other Technology

Offering target: $130,107,279

Filed Nov 3, 2026